Recent News

• 12.08.2025 - Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
• 11.18.2025 - Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA
• 11.13.2025 - Co-Diagnostics Reports Third Quarter 2025 Financial Results
• 11.06.2025 - Co-Dx Fireside Chat with KCSA
• 10.30.2025 - Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Recent Filings

• 12.05.2025 - 8-K Current report
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.13.2025 - 8-K Current report
• 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]